Skip to main content

Table 1 Characteristics of the MFS cohort at 10-year follow-up, N = 47

From: Health-related quality of life in Marfan syndrome: a 10-year follow-up

Females, n (%) 34 (72.3)
Age, mean (SD) 49.9 (11.7)
FBN1 mutation (%) 45 (95.7)
Body mass index, mean (SD) 25.3 (5.7)
β-Adrenergic blocking agents or other antihypertensive medication, n (%) 35 (74.5)
Ascending aortic dilatationa at follow-up, n (%) 43 (91.5)
Aortic surgery during life, n (%) 30 (63.8)
New cardiovascular pathology during follow-up, n (%) 21 (44.7)
New non-cardiovascular pathology during follow-up, n (%) 14 (29.8)
  1. aAccording to the normal material by Devereux et al. Numbers including patients with aortic graft